VAN DRIE; John H.

Patent Applications and Registrations

Patent applications and USPTO patent grants for VAN DRIE; John H..The latest application filed is for "carboxamide derivatives useful as rsk inhibitors".

Company Profile

2.7.12

VAN DRIE; John H. - Richmond CA
Van Drie; John H. - North Andover MA
van Drie; John H. - Andover MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Carboxamide Derivatives Useful As Rsk Inhibitors App 20210186961 - DUNN; Sandra E. ; et al.	2021-06-24
Carboxamide derivatives useful as rsk inhibitors Grant 10,758,530 - Dunn , et al. Sep	2020-09-01
Carboxamide Derivatives Useful As Rsk Inhibitors App 20190134029 - DUNN; Sandra E. ; et al.	2019-05-09
Substituted tetrahydropyrido[3',2':4,5]pyrrolo[1,2-.alpha.]pyrazine-2-carboxamides as RSK inhibitors Grant 10,081,632 - Dunn , et al. September 25, 2	2018-09-25
Carboxamide Derivatives Useful As Rsk Inhibitors App 20170327501 - DUNN; Sandra E. ; et al.	2017-11-16
Substituted tetrahydropyrido[3',2':4,5]pyrrolo[1,2-a]pyrazine-2-carboxamides as RSK inhibitors Grant 9,771,366 - Dunn , et al. September 26, 2	2017-09-26
TETRAHYDROPYRIDO[3',2':4,5]PYRROLO[1,2-a]PYRAZINE-2-CARBOXAMIDE DERIVATIVES USEFUL AS RSK INHIBITORS App 20170240549 - DUNN; Sandra E. ; et al.	2017-08-24
Inhibitors Of Serine Proteases, Particularly Hcv Ns3-ns4a Protease App 20130116169 - Perni; Robert B. ; et al.	2013-05-09
Inhibitors of serine proteases, particularly HCV NS3-NS4A protease Grant 8,217,048 - Perni , et al. July 10, 2	2012-07-10
Inhibitors Of Serine Proteases, Particularly Hcv Ns3-ns4a Protease App 20110104115 - Perni; Robert B. ; et al.	2011-05-05
Inhibitors Of Serine Proteases, Particularly Hcv Ns3-ns4a Protease App 20100173851 - Pitlik; Janos ; et al.	2010-07-08
Inhibitors of serine proteases, particularly HCV NS3-NS4A protease Grant 7,745,444 - Perni , et al. June 29, 2	2010-06-29
Inhibitors of serine proteases, particularly HCV NS3-NS4A protease App 20080311079 - Perni; Robert B. ; et al.	2008-12-18
Inhibitors of serine proteases, particularly HCV NS3-NS4A protease Grant 7,378,422 - Perni , et al. May 27, 2	2008-05-27
Inhibitors of serine proteases, particular HCV NS3-NS4A protease App 20070292933 - Pitlik; Janos ; et al.	2007-12-20
Inhibitors of serine proteases, particularly HCV NS3-NS4A protease Grant 7,273,885 - Pitlik , et al. September 25, 2	2007-09-25
Inhibitors of serine proteases, particularly HCV NS3-NS4A protease App 20050137139 - Perni, Robert B. ; et al.	2005-06-23
Processes for producing optimized pharmacophores App 20050049794 - van Drie, John H. ; et al.	2005-03-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.